Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 594
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2051EpCAMProteinHumanUpregulated for CTCs in patients with HCC. DiagnosticHCC v/s Normal p = 0.595Blood27034142
2052EMAProteinHumanUpregulated for CTCs in patients with HCC. DiagnosticHCC v/s Normal p < 0.05Blood27034142
2053CFL1ProteinHuman cell lines and Mice Upregulated in HBV-HCC Diagnostic and PrognosticHBV-HCC vs normal p < 0.05Tissue27708241
2054ADFPProteinHuman cell lines and Mice Upregulated in HBV-associated HCC Diagnostic and PrognosticHBV-HCC vs normal p < 0.05Tissue27708241
2055TRIM32ProteinHumanUpregulated in HCC tumor tissues and HCC cell lines. Diagnostic and PrognosticHCC v/s Normal; significant predictor for the overall survival time of HCC patients and positively correlated with histological grade, tumor sizes of patients p < 0.05Tissue27573002
2056Putrescine, spermidine, spermine, N-acetylspermine and N-acetylspermidineMetaboliteHumanUpregulated in the plasma of liver cancer patients than lung cancer patients DiagnosticHCC v/s Normal p < 0.05Urine and Plasma27517900
2057Spermine, followed by N-acetylspermidine, putrescine, cadaverine, spermidine, N-acetylspermine and N-acetylputrescineMetaboliteHumanUpregulated in the urine of liver cancer patients than lung cancer patients DiagnosticHCC v/s Normal p < 0.05Urine and Plasma27517900
2058HIF1AProteinHumanUpregulated in at both an mRNA and protein level in patients with PLC Diagnostic and PrognosticCancer v/s Normal; predict survival of patients p < 0.05Tissue27173353
2059VEGFProteinHumanUpregulated in at both an mRNA and protein level in patients with PLC Diagnostic and PrognosticCancer v/s Normal; predict survival of patients p < 0.05Tissue27173353
2060UracilMetaboliteMiceDownregulated Potential Predictive *Cancer v/s Normal; Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2061cis-Aconitate acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2062D-4-PhosphopantothenateMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2063ProgesteroneMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20645-Thymidylic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20652-Phospho-d-glyceric acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2066NiacinamideMetaboliteMiceUpregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2067CortisoneMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2068Imidazoleacetic acid ribotideMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20693-Methyl-2-oxovaleric acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2070PseudoephedrineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20714-PhosphopantothenoylcysteineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2072Pantetheine 4-phosphateMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2073Hippuric acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20743-Hydroxyanthranilic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2075GlycineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2076CreatineMetaboliteMiceUpregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2077CortisolMetaboliteMiceUpregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2078Allantoic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2079Pantothenic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2080CreatinineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2081UreaMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20825-Hydroxyindoleacetic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2083PhytosphingosineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2084Imidazoleacetic acid ribosideMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.01Urine and Plasma27077962
2085Estrogen , Estradiol, AFPProtein + SteroidHumanDownregulated in liver cancer cell. DiagnosticNormal vs liver cancer p < 0.05Serum27060391
2086Estrone plus Estradiol/Testosterone ratioSteroidHumanDownregulated in liver cancer cell. DiagnosticNormal vs liver cancer p < 0.06Serum27060391
2087AFPProteinHumanDownregulated in liver cancer cell. DiagnosticNormal vs liver cancer p < 0.06Serum27060391
2088Aspartate aminotransferase to white blood cell count ratio (AWR)OthersHumanAWR > 5.2 was an adverse predictor of DFS and OS in HCC after hepatectomy PrognosticHCC patients with AWR >5.2 v/s HCC patients with AWR <5.2; predict survival of patients p < 0.01Blood27057915
2089miR-200cmiRNAHumanDownregulated in PSC with control DiagnosticNormal v/s cancer v/s PSC p < 0.05Serum26864161
2090miR-483-5pmiRNAHumanUpregulated in CC compared with controls and PSC. DiagnosticNormal vs cancer p < 0.05Serum26864161
2091miR-194miRNAHumanUpregulated in CC compared with controls. DiagnosticNormal vs cancer p < 0.05Serum26864161
2092DLC1RNAsHumanDownregulated in HCC PrognosticCancer v/s Normal; predict survival of patients p < 0.05Tissue26846339
2093miR-122miRNAHumanUpregulatd in chronic HCV v/s healthy control (with log fold change 3.17) DiagnosticCancer v/s Normal p < 0.05Serum26812693
2094miR-222miRNAHumanUpregulatd in chronic HCV v/s healthy control (with log fold change 3.11) DiagnosticCancer v/s Normal p < 0.01Serum26812693
2095IRF1RNAsHumanUpregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticCancer v/s Normal FDR <0.01Cells26811688
2096GBP1RNAsHumanUpregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2097ICAM1RNAsHumanUpregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2098Foxa1RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2099DHCR7RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2100HMGCS2RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top